Targeted Steroids for ARDS Due to COVID-19 Pneumonia: A Pilot Randomized Clinical Trial

Summary

This trial will determine the safety and estimate efficacy of targeted corticosteroids in mechanically ventilated patients with the hyper-inflammatory sub phenotype of ARDS due to coronavirus disease 2019 (COVID-19) by implementing a Phase 2A clinical trial.

Timeline

Start

2020-09-01

Primary completion

2020-12-31

Completion

2021-01-30

Outcome

Outcome not reported

Stopped (Business): “Funding not received”

Drugs

Indications